Hormone Balance 101: Reading Testosterone, Estradiol, and SHBG Together

Total testosterone measures all circulating testosterone, including the fraction bound to SHBG, the fraction bound loosely to albumin, and the small free fraction. In men, it is the primary marker of androgen status; in women, it contributes to libido, muscle maintenance, and energy.

Estradiol is the most potent estrogen. In women, it drives the menstrual cycle, bone density, and cardiovascular protection; in men, it is produced via aromatization of testosterone and matters for joint health, libido, and bone density. Both too little and too much estradiol produce symptoms.

SHBG is a liver-produced protein that binds sex hormones — primarily testosterone and estradiol — rendering them biologically inactive. SHBG is the gatekeeper: it determines how much of your total hormone is actually available to tissues. High SHBG can make a normal total testosterone reading functionally low; low SHBG can make a borderline reading functionally adequate.

Free testosterone — the unbound, biologically active fraction — is the number that actually correlates with symptoms. It can be measured directly, but it is more commonly calculated from total testosterone, SHBG, and albumin using validated equations (the Vermeulen equation is widely used). This calculated free testosterone is what most functional clinicians rely on.

Consider two men with identical total testosterone of 500 ng/dL. If the first has SHBG of 20 nmol/L, his free testosterone is robust. If the second has SHBG of 60 nmol/L, a much larger fraction of his testosterone is bound and inactive — his free testosterone may be functionally low despite a 'normal' total. This is why reporting total testosterone without SHBG is clinically incomplete.

SHBG is influenced by many factors: thyroid status (hyperthyroidism raises it), insulin resistance (lowers it), liver function, age, and certain medications. This means SHBG itself is a useful marker of metabolic context, not just a correction factor for testosterone.

Reference intervals printed on lab reports are statistical ranges — typically the middle 95% of a tested population. They are not optimal ranges. A 25-year-old and a 65-year-old may both fall 'in range' for total testosterone, but the 65-year-old at the bottom of the range is likely experiencing symptomatic decline relative to his own historical baseline.

Functional practitioners tend to work with tighter, symptom-correlated targets. For men, total testosterone in the 500–800 ng/dL range with a healthy free fraction is a common functional target. For women, total testosterone is far lower (typically 15–70 ng/dL) and estradiol varies across the menstrual cycle, making single-point estradiol readings difficult to interpret without cycle context.

This is precisely why trend data matters. A single estradiol reading is nearly meaningless without knowing where in the cycle it was drawn. Six months of readings, collected at consistent timepoints, reveal the pattern.

Testosterone replacement therapy (TRT) and hormone replacement therapy (HRT) both require titration — adjusting dose based on response. The standard clinical cadence is a blood draw 6–8 weeks after a dose change, which captures the steady-state. But between those checkpoints, patients are flying blind.

Monthly at-home capillary testing lets patients and clinicians see the trajectory between visits. If testosterone is climbing too fast and estradiol is aromatizing upward alongside it, the trend is visible before the next scheduled appointment. If a dose adjustment produces a stable, symptom-relieving plateau, that is confirmed with data rather than guesswork.

For women on HRT, monthly estradiol tracking across cycles helps identify whether a regimen is producing stable levels or erratic fluctuations — information that single-point lab draws simply cannot provide.

Patients in Metro Detroit who want clinician-guided interpretation of a hormone panel have strong local options. Monarch Lifestyle Medicine (www.monarchlifestylemed.com) offers lifestyle-medicine-informed hormone evaluation. For patients whose hormone concerns intersect with facial aesthetics or reconstructive needs — for example, post-weight-loss or age-related changes — Detroit Face MD (www.detroitfacemd.com) provides facial plastic and reconstructive expertise, and HOK Detroit (www.hokdetroit.com) connects patients with broader wellness and aesthetic coordination.

The Van Dutch (www.thevandutch.com) and Sobh Orthodontics (www.sobhortho.com) round out a network of Detroit-area practices that patients may engage as part of a comprehensive wellness approach. None of these replace endocrinology care for diagnosed hormone disorders, but they reflect the region's growing integrative wellness infrastructure that at-home testing data can support.